Podcasts by Category
JAMA Clinical Reviews

- 653 - Idiosyncratic Drug-Induced Liver Injury: Diagnosis, Risk Factors, and Management
Idiosyncratic drug-induced liver injury is damage caused by prescription or over-the-counter medications or herbal dietary supplements that is not dose-dependent. JAMA Associate Editor Beverly Forsyth, MD, speaks with author Naga Chalasani, MD, of Indiana University School of Medicine about risk factors, evaluation, and treatment of patients with idiosyncratic drug-induced liver injury. Related Content:
Idiosyncratic Drug-Induced Liver Injury Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World DataWed, 04 Nov 2026 - 16min - 652 - Diagnosis and Management of Childhood Obesity
Childhood obesity affects approximately 15% of children aged 2 to 12 and is associated with adverse health outcomes in adulthood. Author Claudia K. Fox, MD, MPH, of the University of Minnesota Medical School joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss epidemiology, diagnosis, and treatment of childhood obesity. Related Content:
Obesity in Children Aged 2 to 12 YearsWed, 21 Oct 2026 - 17min - 651 - Heart Transplant for Advanced Heart Failure
Heart transplant for patients with advanced heart failure can lead to improved survival and quality of life. Author JoAnne Lindenfeld, MD, of Vanderbilt University joins JAMA Associate Editor David Simel, MD, MHS, to discuss indications, transplant evaluation, management after transplant, long-term complications, and survival. Related Content:
Heart Transplant for Advanced Heart FailureMon, 12 Oct 2026 - 22min - 650 - Narcolepsy: A Review
Narcolepsy is a chronic neurologic disorder that causes severe daytime sleepiness and impaired quality of life. Author Tom Scammell, MD, of Harvard Medical School joins JAMA Deputy Editor Karen Lasser, MD, MPH, to discuss the etiology, clinical presentation, diagnostic evaluation, and treatment of narcolepsy. Related Content:
Narcolepsy The Orexin System—A Key Component of Sleep Regulatory Networks and Involvement in NarcolepsyMon, 05 Oct 2026 - 20min - 649 - Influenza, RSV, and COVID-19 Vaccines: Effectiveness, Safety, and Trust in 2026
Respiratory virus vaccine effectiveness and safety for influenza, RSV, and COVID-19 are reviewed, including new evidence, risks, and recommendations. JAMA Deputy Editor Preeti Malani, MD, MSJ, speaks with Rochelle Walensky, MD, MPH, professor of medicine at Harvard Medical School and former CDC Director, about vaccine data, public trust, and the 2026 respiratory virus season. Related Content:
Respiratory Season Virus Vaccines RSV Immunization Effectiveness and Safety for the 2026-2027 Respiratory Season Influenza Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season COVID-19 Vaccine Effectiveness and Safety for the 2026-2027 Respiratory SeasonWed, 30 Sep 2026 - 14min - 648 - Vaccines for Cancer Treatment
Cancer vaccines stimulate immune cells to recognize proteins or mutations found on or within cancer cells, facilitating destruction of cancer cells. Several vaccines are approved and others are in development for cancer treatment. Author Nora Disis, MD, JAMA Deputy Editor and Editor in Chief of JAMA Oncology, discusses cancer vaccines and more with JAMA Deputy Editor Mary McDermott, MD. Related Content:
Vaccines for CancerMon, 21 Sep 2026 - 20min - 647 - Idiopathic Normal Pressure Hydrocephalus: Diagnosis and Treatment
Idiopathic normal pressure hydrocephalus (iNPH) affects approximately 1% to 4% of adults aged 65 years and older and is associated with gait impairment, cognitive decline, and urinary dysfunction. Author Mark G. Luciano, MD, PhD, from Johns Hopkins University, discusses this and more with JAMA Deputy Editor Kristin Walter, MD, MS. Related Content:
Idiopathic Normal Pressure HydrocephalusMon, 14 Sep 2026 - 19min - 646 - Rheumatoid Arthritis
Rheumatoid arthritis can affect any synovial joint and cause irreversible damage, but early diagnosis and treatment with DMARDs can reduce inflammation and lower the risk of joint destruction. JAMA Associate Editor David Simel, MD, MHS, is joined by review coauthor Josef Smolen, MD, to discuss this topic. Related Content:
Rheumatoid Arthritis in AdultsThu, 10 Sep 2026 - 23min - 645 - An Overview of Postural Orthostatic Tachycardia Syndrome (POTS)
POTS is a chronic autonomic disorder characterized by excessive orthostatic tachycardia and multisystem symptoms that affects an estimated 0.1% to 1% of the US population. Author Satish Raj, MD, MSCI, of University of Calgary Cumming School of Medicine joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss current evidence about the pathophysiology, diagnosis, and management of POTS. Related Content:
Postural Orthostatic Tachycardia Syndrome (POTS)Mon, 24 Aug 2026 - 28min - 644 - Medication Treatments for Alcohol Use Disorder
Naltrexone, acamprosate, disulfiram, and topiramate are effective but underused medications for treatment of alcohol use disorder. Author Stephen Holt, MD, MS, of Yale School of Medicine joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss first-line pharmacotherapy for alcohol use disorder and important safety, efficacy, and hospital initiation considerations. Related Content:
Medications for Alcohol Use DisorderWed, 19 Aug 2026 - 20min - 643 - Liquid Biopsy Tests for Cancer
Circulating tumor DNA (ctDNA)(liquid biopsies) can help monitor cancer progression, detect residual cancer after treatment, and identify genetic changes within cancer cells that could affect treatment response. Author Ben Ho Park, MD, PhD, of the Vanderbilt-Ingram Cancer Center discusses current evidence regarding use of liquid biopsies in management of cancer with JAMA Deputy Editor Mary McGrae McDermott, MD. Related Content:
Liquid Biopsies for Cancer Applications of Liquid Biopsy for Surgical Patients With CancerMon, 10 Aug 2026 - 23min - 642 - Patient-Clinician Communication About Physical Activity
Physical activity is an effective component of care for people with chronic medical conditions. In this podcast, JAMA Insights author Alessio Bricca, PhD, University of Southern Denmark, discusses adaptable methods to promote physical activity in patients with chronic medical conditions with host Anne Rentoumis Cappola, MD, ScM. Related Content:
Communicating With Patients About Physical ActivityThu, 06 Aug 2026 - 10min - 641 - Classic Hodgkin Lymphoma
Hodgkin lymphoma is a relatively rare disease, with approximately 82 409 incident cases reported globally in 2022, and 8720 cases reported in the US in 2025. Author Alison Moskowitz, MD, of Memorial Sloan Kettering Cancer Center joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss current evidence about the diagnosis and management of Hodgkin lymphoma in adults. Related Content:
Classic Hodgkin LymphomaMon, 03 Aug 2026 - 20min - 640 - The Sleep-Weight Connection
Suboptimal sleep quality and quantity are associated with higher body mass index and more difficulty losing weight. In this podcast, JAMA Insights author Atul Malhotra, MD, from the University of California, San Diego, discusses evidence regarding sleep and obesity with JAMA Deputy Editor Mary McDermott, MD. Related Content:
Sleep Health and ObesityWed, 29 Jul 2026 - 13min - 639 - Management of Dyslipidemia
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of global mortality and is strongly associated with cumulative exposure to atherogenic lipoproteins across the lifespan. Author Amber E. Johnson, MD, MS, MBA, of the University of Chicago joins JAMA Senior Editor Philip Greenland, MD, to discuss the ACC/AHA guideline on management of dyslipidemia. Related Content:
Dyslipidemia Evaluation and Management Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin TherapyMon, 20 Jul 2026 - 23min - 638 - Hip Fractures: Management and Prevention
Hip fractures are a leading cause of disability and death in older adults. This episode summarizes risk factors, prevention, and medical and surgical management of hip fractures. JAMA Deputy Editor Mary M. McDermott, MD, interviews Douglas Kiel, MD, MPH, of Harvard Medical School and Marcus Institute for Aging Research. Related Content:
Hip FracturesThu, 16 Jul 2026 - 19min - 637 - Alcohol-Related Liver Disease
Alcohol-related liver disease is the leading cause of liver-related morbidity and mortality and the most common indication for liver transplant in Europe and the US. Author Aleksander Krag, MD, PhD, of the University of Southern Denmark joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss a recent review on this topic published in JAMA. Related Content:
Alcohol-Related Liver DiseaseMon, 06 Jul 2026 - 20min - 636 - An Overview of Familial Hypercholesterolemia
Worldwide, heterozygous familial hypercholesterolemia (FH) affects approximately 1 in 250 to 350 individuals. Author James Stein, MD, of the University of Wisconsin School of Medicine and Public Health joins JAMA Deputy Editor Karen Lasser, MD, MPH, to discuss the epidemiology, diagnosis, and treatment of both homozygous and heterozygous FH. Related Content:
Familial HypercholesterolemiaMon, 29 Jun 2026 - 10min - 635 - Transforming Communication Between Patients and Clinicians
Patient portal messaging continues to expand across health systems, and it has become an increasingly important method for patient-clinician communication. Authors Michal Mankowski, PhD, assistant professor, and Jane Long, MD, research resident, both from the Department of Surgery at NYU, discuss their new research letter with JAMA Deputy Editor Joseph Ross, MD, MHS. Related Content:
Trends in Patient Portal Messages, Office Visits, and Telephone Encounters National Trends in Patient Messaging—The Growing Electronic InboxMon, 22 Jun 2026 - 15min - 634 - Low Back Pain: Diagnosis and Treatment
Nonspecific low back pain is a leading cause of disability, with most cases lacking a clear anatomic cause. This episode reviews risk factors, diagnosis, and current evidence-based treatments for acute and chronic low back pain. JAMA Deputy Editor Mary M. McDermott, MD, interviews author James McAuley, PhD, of the University of New South Wales. Related Content:
Low Back Pain What Is Low Back Pain?Mon, 15 Jun 2026 - 26min - 633 - Survivors of Cyanotic Congenital Heart Disease
Cyanotic congenital heart diseases occur in approximately 0.2% of live births in the US, but survival to adulthood is common with current surgical interventions. JAMA Associate Editor David Simel, MD, MHS, speaks with author Michael Landzberg, MD, who coauthored a recent review in JAMA on this topic. Related Content:
Survivors of Cyanotic Congenital Heart DiseaseMon, 08 Jun 2026 - 23min - 632 - Point-of-Care Ultrasound for the Diagnosis of Pneumonia: A Review
Community-acquired pneumonia (CAP) accounts for 1.4 million emergency department visits and 740 000 hospitalizations annually in the US. Author Andre Kumar, MD, MEd, of Stanford University School of Medicine joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the use of point-of-care ultrasound for diagnosis of CAP. Related Content:
Point-of-Care Ultrasound for the Diagnosis of Pneumonia Bedside Lung Ultrasound in Emergency (BLUE) for Evaluation of DyspneaWed, 03 Jun 2026 - 16min - 631 - Cesarean Delivery on Request
Cesarean delivery on maternal request requires individualized counseling. Reduced risks of pelvic floor disorders should be weighed against surgical risks and future risks including abnormal placentation. Author Marianna Alperin, MD, MS, from UC San Diego School of Medicine, discusses this and more with JAMA Deputy Editor Linda Brubaker, MD. Related Content:
Cesarean Delivery on Maternal Request Cesarean Delivery—Reply Cesarean DeliveryWed, 27 May 2026 - 15min - 630 - Diet and Exercise Recommendations for Patients Taking GLP-1 Receptor Agonists
The GLP-1 receptor agonists reduce appetite and greatly facilitate weight loss. Robert Kushner, MD, of Northwestern University Feinberg School of Medicine joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss appropriate diet and exercise recommendations for patients receiving GLP-1 receptor agonists for weight loss. Related Content:
Lifestyle Modification and Incretin-Based Therapy for Obesity The Conundrum of Exercise for Weight Management in the GLP-1 Receptor Agonist EraWed, 20 May 2026 - 14min - 629 - An Overview of Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS), which affects about 25 000 individuals in the US, causes progressive weakness but has varied presentations. Several FDA-approved medications are now available for ALS. Author John Ravits, MD, of UC San Diego School of Medicine joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss current evidence regarding diagnosis and treatment of ALS. Related Content:
Amyotrophic Lateral Sclerosis Pridopidine in Amyotrophic Lateral Sclerosis What Is Amyotrophic Lateral Sclerosis? CNM-Au8 in Amyotrophic Lateral Sclerosis Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis Traumatic Brain Injury and Risk of Amyotrophic Lateral SclerosisMon, 11 May 2026 - 17min - 628 - Hepatitis B: Global Insights on Transmission and Treatment
Hepatitis B virus (HBV) infection affects around 254 million people worldwide and causes more than 1 million deaths annually. Author Anna Lok, MD, from the University of Michigan discusses HBV transmission, screening, and treatment with JAMA Associate Editor Beverly Forsyth, MD. Related Content:
Hepatitis B Hepatitis B Virus Treatment Gaps in the US Tenofovir and Hepatitis B Virus Transmission During Pregnancy US Newborn Hepatitis B Virus Vaccination RatesMon, 04 May 2026 - 21min - 627 - Review of Cardiac Resynchronization Therapy
Heart failure (HF) affects more than 64 million individuals worldwide, and 20% to 30% of patients with HF and systolic dysfunction have cardiac dyssynchrony due to conduction system disease. JAMA Review author Mihail Chelu, MD, PhD, of Baylor College of Medicine discusses cardiac resynchronization therapy with JAMA Associate Editor David Simel, MD, MHS. Related Content:
Cardiac Resynchronization Therapy Leadless Ultrasound-Based Cardiac Resynchronization System in Heart FailureMon, 27 Apr 2026 - 19min - 626 - Prepregnancy Care and Counseling to Improve Maternal and Neonatal Outcomes
In the US, approximately 66% of reproductive-aged women have at least 1 modifiable risk factor for adverse pregnancy outcomes. Authors and ob-gyns Kylie Cooper, MD, and Daniel Breitkopf, MD, both from the Mayo Clinic, discuss ways to reduce maternal morbidity and mortality and improve neonatal outcomes with JAMA Senior Editor Karen Lasser, MD, MPH. Related Content:
Prepregnancy Care and CounselingMon, 20 Apr 2026 - 18min - 625 - Diagnosis and Management of Endometrial Cancer
Endometrial cancer accounts for 95% of uterine cancers, which are the fourth most common cancer in women in the US. Author Karen McLean, MD, PhD, of Roswell Park Comprehensive Cancer Center joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence about diagnosis and treatment of endometrial cancer. Related Content:
Endometrial CancerMon, 13 Apr 2026 - 14min - 624 - Evaluating for Pediatric Concussion
Explore evidence-based clinical signs, diagnostic accuracy, and practical assessment strategies to optimize care with an in-depth look at the latest information on pediatric concussion. JAMA Review author Sonal N. Shah, MD, MPH, of Boston Children's Hospital, discusses this and more with JAMA Associate Editor David Simel, MD, MHS. Related Content:
Does This Child Have a Concussion? Even Mild Concussions Tied to Worse Cognition Later in Life Vestibular/Ocular Motor Screening (VOMS) in Suspected Concussion Balance and Gait Assessment Including Modified BESS Cervical Spine Examination in Suspected ConcussionMon, 06 Apr 2026 - 16min - 623 - Iron Deficiency in Adults: Advances in Diagnosis and Treatment
Absolute iron deficiency with or without anemia affects about 2 billion people worldwide and 14% of adults in the US. Discover causes, diagnosis, and best practices for oral and intravenous iron therapy in adults in this discussion between Michael Auerbach, MD, from Georgetown University School of Medicine, and JAMA Associate Editor Margaret Wheeler, MD. Related Content:
Iron Deficiency in AdultsMon, 30 Mar 2026 - 16min - 622 - From the JAMA Network: Incidental Rotator Cuff Abnormalities on Magnetic Resonance Imaging
Interview with Thomas Ibounig, MD, author of Incidental Rotator Cuff Abnormalities on Magnetic Resonance Imaging and Brian T. Feeley, MD, author of Magnetic Resonance Imaging Abnormalities and Incidental Age-Related Changes. Hosted by Eve Rittenberg, MD. Related Content:
Incidental Rotator Cuff Abnormalities on Magnetic Resonance Imaging Magnetic Resonance Imaging Abnormalities and Incidental Age-Related ChangesSat, 28 Mar 2026 - 15min - 621 - Resistant Hypertension: Diagnosis and Management
Resistant hypertension affects about 10% of those treated for hypertension. Managing it involves lowering sodium intake, exercising, losing weight, reducing alcohol consumption, and using optimal diuretics, combination pills, and mineralocorticoid antagonists. Author Michel Azizi, MD, PhD, from Hospital European Georges Pompidou in France discusses this and more with JAMA Associate Editor David L. Simel, MD, MHS. Related Content:
Diagnosis and Management of Resistant HypertensionMon, 23 Mar 2026 - 18min - 620 - Update on Peanut Allergy
Peanut allergy affects about 2% of people in the US and most commonly develops in early childhood. Peanut introduction during infancy has led to decreased prevalence of peanut allergy. Author Elissa Abrams, MD, MPH, of the University of Manitoba joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the clinical presentation and methods to diagnose, treat, and decrease the risk of peanut allergy. Related Content:
Peanut AllergyThu, 19 Mar 2026 - 18min - 619 - Obesity-Related Cancer
Overweight and obesity may cause 10% of new cancer diagnoses annually in the US. In this JAMA Review in the Translational Science series, author Neil Iyengar, MD, of Emory University discusses the biological pathways that may promote cancer in people with overweight or obesity and potential therapies with JAMA Deputy Editor Mary McDermott, MD. Related Content:
Obesity and CancerMon, 09 Mar 2026 - 21min - 618 - Diagnosis and Treatment of Chronic, Noninfectious Diarrhea
Chronic noninfectious diarrhea affects approximately 6% to 7% of adults in the US and significantly impairs quality of life. Author William Chey, MD, of the University of Michigan joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss strategies for diagnosis and treatment of chronic, noninfectious diarrhea. Related Content:
Chronic, Noninfectious DiarrheaMon, 02 Mar 2026 - 19min - 617 - Does This Patient Have Volume Overload? The Rational Clinical Examination
Accurate assessment of intravascular volume facilitates decisions about fluid management in patients with volume overload. Author Edmund A. Liles Jr, MD, of the University of Utah joins JAMA Associate Editor David Simel, MD, MHS, to discuss best evidence from physical exam findings including ultrasound, radiographs, and lab studies for determining volume overload in spontaneously breathing patients. Related Content:
Does This Patient Have Volume Overload?Mon, 23 Feb 2026 - 18min - 616 - Type 1 Diabetes: Diagnosis and Management
Type 1 diabetes affects approximately 2 million people in the US and 8.4 million people worldwide. Author Desmond Schatz, MD, of the University of Florida joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss current evidence regarding diagnosis and treatment of type 1 diabetes. Related Content:
Type 1 DiabetesMon, 16 Feb 2026 - 16min - 615 - Pharmaceutical Pricing: JAMA Talks With Mark Cuban
Mark Cuban, entrepreneur, investor, and cofounder of the Mark Cuban Cost Plus Drug Company, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the role of pharmacy benefit managers, insurance formularies, and opaque pricing practices that shape how most Americans access prescription drugs. Hear why he thinks doctors are the good guys in a broken system. Related Content:
Pharmaceutical Pricing—JAMA Talks With Mark CubanThu, 12 Feb 2026 - 33min - 614 - Medications for Opioid Use Disorder, Withdrawal, and Overdose
Opioid use disorder is the third most prevalent substance use disorder worldwide. Author Alexander Walley, MB, MSc, of Boston Medical Center and Boston University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the efficacy, safety, and practical considerations of treating patients with medications for opioid use disorder, opioid withdrawal, and opioid overdose. Related Content:
Medications for Opioid Use Disorder, Opioid Withdrawal, and Opioid OverdoseWed, 11 Feb 2026 - 23min - 613 - Ovarian Cancer Prevention With Opportunistic Fallopian Tube Removal
Ovarian cancer may be prevented with removal of the fallopian tubes during pelvic or select abdominal surgery in eligible women. This procedure, opportunistic salpingectomy, can be offered to more eligible women. Author Jurgen M. Piek, MD, PhD, of the Catharina Cancer Institute discusses this and more with JAMA Deputy Editor Linda Brubaker, MD, MS. Related Content:
Opportunistic Salpingectomy for Prevention of Tubo-Ovarian CarcinomaMon, 02 Feb 2026 - 17min - 612 - IgA Nephropathy in Adults
IgA nephropathy is a chronic kidney disease involving deposition of IgA-containing immune complexes in the glomerulus, which often causes kidney failure within 10 to 20 years. Author Michelle Marie O'Shaughnessy, MB, BCh, BAO, MS, of Galway University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the symptoms, risk factors, diagnosis, treatment, and prognosis of IgA nephropathy in adults. Related Content:
IgA Nephropathy in AdultsMon, 26 Jan 2026 - 27min - 611 - Restless Legs Syndrome
Restless legs syndrome is a sleep-related neurologic disorder that causes an overwhelming urge to move the limbs, which can cause substantial sleep disturbance. Author John W. Winkelman, MD, PhD, of Harvard Medical School joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the symptoms, risk factors, diagnosis, and treatment of restless legs syndrome. Related Content:
Restless Legs SyndromeWed, 21 Jan 2026 - 23min - 610 - A Conversation About the FDA's Regulation of Mifepristone
Mifepristone used with misoprostol is the most common abortion regimen in the US. It is also a focal point of reproductive health policy and politics, with controversy over its legal status and regulation by the US Food and Drug Administration (FDA). Author G. Caleb Alexander, MD, MS, from Johns Hopkins discusses this and more with JAMA Deputy Editor Joseph S. Ross, MD, MHS. Related Content:
The US Food and Drug Administration's Regulation of Mifepristone Politics, Science, and the Future of FDA Drug RegulationMon, 12 Jan 2026 - 20min - 609 - Gastric Cancer Worldwide
Incidence rates of gastric cancer in younger individuals are on the rise and gastric cancer is the fifth-leading cause of cancer-related deaths worldwide. JAMA Review author Haeseong Park, MD, MPH, from the Dana Farber Cancer Institute, discusses this and more with JAMA Senior Editor Karen Lasser, MD, MPH. Related Content:
Gastric CancerWed, 07 Jan 2026 - 13min - 608 - JAMA Editors' Choice 2025: Clinical Reviews Podcasts
JAMA Deputy Editor Mary McDermott, MD, and JAMA Deputy Editor Kristin Walter, MD, MS, highlight their selections of top JAMA Clinical Reviews podcasts in 2025. Related Content:
Managing Adverse Effects of Obesity Medications Diagnosis and Management of Hypothyroidism Type 2 Diabetes: Diagnosis and Current Guidelines for Treatment Managing Adverse Effects of Incretin-Based Medications for Obesity Hypothyroidism Diagnosis and Treatment of Type 2 Diabetes in Adults JAMA Editors' Choice 2024: Clinical Reviews PodcastsTue, 30 Dec 2025 - 16min - 607 - From the JAMA Network: JAMA Research of the Year With Editor in Chief Kirsten Bibbins-Domingo
In this episode, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Medical News Director Jennifer Abbasi discuss the journal's inaugural Research of the Year roundup. Related Content:
Research of the Year 2025Fri, 26 Dec 2025 - 16min - 606 - WHO Guideline on the Use and Indications of GLP-1 Therapies for the Treatment of Obesity in Adults
Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease. WHO recently published a guideline in JAMA on the use and indications of GLP-1 therapies for the treatment of #obesity in adults. Francesca Celletti, MD, PhD, and Ezekiel Emanuel, MD, PhD, join JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss. Related Content:
World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in AdultsWed, 17 Dec 2025 - 33min - 605 - Head and Neck Cancer
Head and neck cancer is the seventh most common cancer worldwide and is commonly associated with tobacco and alcohol use, or human papillomavirus (HPV) infection. Author Lara Dunn, MD, of Memorial Sloan Kettering Cancer Center joins JAMA Associate Editor Margaret Wheeler, MD, to discuss the epidemiology, risk factors, diagnosis, treatment, and prognosis of head and neck cancer. Related Content:
Head and Neck CancerMon, 15 Dec 2025 - 18min - 604 - How Climate Change Affects Allergic Rhinitis and Sinusitis
Allergic rhinitis affects about 1 in 6 US adults. A recent JAMA Insights summarizes evidence regarding the associations of climate change and air pollution with allergic rhinitis and sinusitis. The discussion includes prevention and management strategies. Coauthor Neelima Tummala, MD, joins JAMA Deputy Editor Mary McDermott, MD, to discuss. Related Content:
Climate Change, Allergic Rhinitis, and SinusitisWed, 03 Dec 2025 - 12min - 603 - Cannabis and Cannabinoids for Therapeutic Purposes
Clinicians should weigh benefits against risks when engaging patients in informed discussions about cannabis or cannabinoid use. Kevin Hill, MD, MHS, of Harvard Medical School joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence about the therapeutic use of cannabis and cannabinoids in adults, potential harms, and evidence-based clinical guidance. Related Content:
Therapeutic Use of Cannabis and CannabinoidsWed, 26 Nov 2025 - 13min - 602 - Diagnosis and Treatment of Peripheral Neuropathy
Peripheral neuropathy affects approximately 1% of adults worldwide and can be associated with significant disability. Author Michelle Mauermann, MD, of the Mayo Clinic in Minnesota joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss diagnosis and optimal management of peripheral neuropathy. Related Content:
Peripheral NeuropathyMon, 17 Nov 2025 - 22min - 601 - Diagnosis and Treatment of MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD), an increasingly prevalent condition among adults worldwide, is associated with liver-related complications, hepatocellular carcinoma, and certain extrahepatic cancers. Author Norbert Stefan, MD, from the University Hospital of Tübingen in Tübingen, Germany, discusses this and more with JAMA Deputy Editor Kristin Walter, MD, MS. Related Content:
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults-----------------------------------
Mon, 10 Nov 2025 - 26min - 600 - Moving Toward a Safer World by 2040
The JAMA Summit on Firearm Violence convened 60 thought leaders from a wide array of disciplines to chart a roadmap that could lead to substantial reductions in firearm harms by 2040. Frederick P. Rivara, MD, MPH, of the University of Washington joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the Summit and steps that could lead to a safer world by 2040. Related Content:
Toward a Safer World by 2040 Reducing Firearm Violence and Harms-----------------------------------
Mon, 03 Nov 2025 - 15min - 599 - Treatment of Keratinocyte Carcinoma
Keratinocyte carcinomas, which include basal cell carcinoma and squamous cell carcinoma, are common forms of skin cancer. Approximately 5.4 million keratinocyte carcinomas are diagnosed in the US annually. Author Mackenzie R. Wehner, MD, MPhil, of the University of Texas MD Anderson Cancer Center joins JAMA Associate Editor David Simel, MD, MHS, to discuss treatment of these types of nonmelanoma skin cancer. Related Content:
Keratinocyte Carcinoma-----------------------------------
Thu, 30 Oct 2025 - 19min - 598 - Lung Cancer in Nonsmoking Individuals
Lung cancer in nonsmoking individuals is increasing worldwide and currently accounts for 15% to 20% of lung cancer cases globally. Benjamin Solomon, PhD, of the Peter MacCallum Cancer Centre in Melbourne, Australia, discusses the epidemiology and treatment of lung cancer in nonsmoking patients with JAMA Deputy Editor Kristin Walter, MD, MS. Related Content:
Lung Cancer in Nonsmoking Individuals-----------------------------------
Mon, 20 Oct 2025 - 17min - 597 - What Clinicians Should Know About Syphilis
Syphilis infections have increased in the US and worldwide over the past decade. Left untreated, syphilis can cause blindness, deafness, psychosis, dementia, and peripheral nerve damage, and can cause congenital syphilis. Author Franco Chevalier, MD, MPH, from the San Francisco Department of Public Health discusses this and more with JAMA Deputy Editor Preeti Malani, MD, MSJ. Related Content:
Syphilis-----------------------------------
Thu, 16 Oct 2025 - 15min - 596 - Microplastic Pollution and Human Health
Microplastics, defined as plastics smaller than 5 mm, have been detected in human tissues at increasing rates and are associated with potential adverse health effects. Author David Christiani, MD, MPH, from the Department of Environmental Health at Harvard T.H. Chan School of Public Health, discusses this topic and more with JAMA Deputy Editor Kristin Walter, MD, MS. Related Content:
Microplastics and Human Health-----------------------------------
Wed, 15 Oct 2025 - 15min - 595 - Treatment of Severe Refractory Asthma
Severe refractory asthma, which affects approximately 1% to 5% of patients with asthma, is associated with increased morbidity and mortality. Author Juan Carlos Cardet, MD, MPH, of the University of South Florida joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the management of patients with severe refractory asthma, including first-line medications and biologics. Related Content:
Management of Severe Refractory Asthma-----------------------------------
Wed, 01 Oct 2025 - 14min - 594 - From the JAMA Network: Acetaminophen Use in Pregnancy and Risk of Autism
Epidemiologist Brian Lee, PhD, discusses his study on acetaminophen use during pregnancy and children's risk of autism and other neurodevelopmental disorders in this interview with JAMA Deputy Editor Linda Brubaker, MD. Related Content:
Acetaminophen Use in Pregnancy—Study Author Explains the Data-----------------------------------
Tue, 30 Sep 2025 - 16min - 593 - Five Things to Do When Communicating Medical Numbers
Health care professionals often use numbers to guide decisions, monitor patient health, and communicate information. Author Angela Fagerlin, PhD, of the University of Utah joins JAMA Senior Editor Anne Cappola, MD, ScM, to discuss how providing numerical information may be helpful in shared decision-making with patients. Related Content:
How to Communicate Medical Numbers-----------------------------------
Wed, 24 Sep 2025 - 15min - 592 - Superficial Vein Thrombosis
Superficial vein thrombosis (SuVT) is characterized by thrombus formation in the superficial veins, typically in the lower or upper extremities. In this podcast, the coauthor of a JAMA review on SuVT, Behnood Bikdeli, MD, MS, discusses pathophysiology, risk factors, diagnosis, and treatment of SuVT with JAMA Deputy Editor Mary McDermott, MD. Related Content:
Superficial Vein Thrombosis-----------------------------------
Mon, 15 Sep 2025 - 19min - 591 - Diagnosis and Management of Hypothyroidism
Untreated hypothyroidism can cause serious health complications such as heart failure and myxedema coma. Author Maria Papaleontiou, MD, of the University of Michigan joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence regarding the epidemiology, diagnosis, clinical presentation, and treatment of primary overt hypothyroidism in nonpregnant adults. Related Content:
Hypothyroidism-----------------------------------
Wed, 03 Sep 2025 - 13min - 590 - From the JAMA Network: Over-the-Counter Hearing Aid–Enabled Earbuds
Interview with Alexander Chern, MD, author of Over-the-Counter Hearing Aid–Enabled Earbuds—Merging Hearing Health and Technology. Hosted by Paul C. Bryson, MD, MBA. Related Content:
Over-the-Counter Hearing Aid–Enabled Earbuds—Merging Hearing Health and Technology-----------------------------------
Fri, 29 Aug 2025 - 13min - 589 - Diagnosis and Management of Cutaneous Melanoma
The incidence and prevalence of cutaneous melanoma in the US and worldwide have increased over the last 5 decades. JAMA Review Author John Kirkwood, MD, discusses the epidemiology, risk factors, treatment, and prevention of melanoma with JAMA Deputy Editor Kristin Walter, MD, MS. Related Content:
Cutaneous Melanoma-----------------------------------
Mon, 25 Aug 2025 - 22min - 588 - Diagnosis and Treatment of Hemorrhoidal Disease
Hemorrhoidal disease, pathology of the tissue lining the anal canal, affects approximately 10 million individuals in the US. Author Jean H. Ashburn, MD, of Wake Forest University School of Medicine and JAMA Senior Editor Karen E. Lasser, MD, MPH, discuss the current evidence on the epidemiology, pathophysiology, diagnosis, and treatment of hemorrhoidal disease. Related Content:
Hemorrhoidal Disease-----------------------------------
Mon, 18 Aug 2025 - 18min - 587 - Treatment of Complicated Staphylococcus aureus Bacteremia
Dalbavancin, a long-acting IV lipoglycopeptide, may be an option for the treatment of complicated Staphylococcus aureus bacteremia without requiring long-term IV access. Author Thomas L. Holland, MD, MSc, from Duke University School of Medicine discusses key points of the DOTS randomized clinical trial and more with JAMA Deputy Editor Preeti Malani, MD, MSJ. Related Content:
Dalbavancin for Treatment of Staphylococcus aureus Bacteremia Management of Staphylococcus aureus Bacteremia-----------------------------------
Wed, 13 Aug 2025 - 11min - 586 - Diagnosis and Management of Prostatitis
Prostatitis affects approximately 9.3% of men in their lifetime and includes acute and chronic bacterial infection and nonbacterial chronic prostatitis with chronic pelvic pain syndrome. Author Minh N. Pham, MD, from University of North Carolina School of Medicine discusses this and more with JAMA Deputy Editor Mary M. McDermott, MD. Related Content:
Prostatitis-----------------------------------
Mon, 11 Aug 2025 - 17min - 585 - Geroscience in Medicine
Geroscience aims to define and modify biologic pathways associated with aging and age-related diseases. Author Stephen B. Kritchevsky, PhD, of the Wake Forest University School of Medicine and JAMA Deputy Editor Mary M. McDermott, MD, discuss current evidence regarding geroscience, human health, and promising therapies that may slow aging and age-related decline. Related Content:
Geroscience-----------------------------------
Thu, 07 Aug 2025 - 16min - 584 - Managing Adverse Effects of Obesity Medications
New medications for obesity, such as semaglutide and tirzepatide, are highly effective but can be associated with adverse effects that reduce adherence. Obesity expert and author Robert Kushner, MD, joins JAMA Deputy Editor Mary McDermott, MD, to discuss a recent JAMA Insights article on managing adverse effects of obesity medications. Related Content:
Managing Adverse Effects of Incretin-Based Medications for Obesity-----------------------------------
Tue, 29 Jul 2025 - 12min - 583 - Patent Foramen Ovale-Associated Stroke
A patent foramen ovale (PFO) is present in approximately 25% of all adults. Author David M. Kent, MD, MS, of Tufts Medical Center and JAMA Associate Editor David Simel, MD, MHS, discuss how to evaluate the likelihood that a PFO was causal in a patient with a cryptogenic ischemic stroke, and closure of a PFO to lower the incidence of recurrent strokes for affected patients. Related Content:
Patent Foramen Ovale and Stroke Patent Foramen Ovale and Dysarthria in a Man in His 60s Management of Patients With a Patent Foramen Ovale With History of Stroke or TIA Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke Transesophageal Echocardiogram Detecting a High-Risk Patent Foramen Ovale-----------------------------------
Mon, 28 Jul 2025 - 20min - 582 - Diverticulitis: Diagnosis and Management
Approximately 200 000 people are hospitalized for diverticulitis each year in the US, and the incidence of diverticulitis is increasing, particularly among younger people. Author Anthony Charles, MD, MPH, of the University of Vermont and JAMA Deputy Editor Mary M. McDermott, MD, discuss current evidence regarding the epidemiology, diagnosis, and treatment of diverticulitis. Related Content:
Diverticulitis Quality-of-Life and Recurrence Outcomes Following Laparoscopic Elective Sigmoid Resection vs Conservative Treatment Following Diverticulitis Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor–Positive, Node-Negative Breast Cancer-----------------------------------
Thu, 24 Jul 2025 - 15min - 581 - Ovarian Cancer: Clinical Risk Factors and Treatment
A recent Review discusses the epidemiology, risk factors, diagnosis, and treatment of ovarian cancer. William Cliby, MD, and John Weroha, MD, PhD, both from the Mayo Clinic in Rochester, Minnesota, discuss this and more with JAMA Associate Editor Margaret Wheeler, MD. Related Content:
Ovarian Cancer Endometriosis Typology and Ovarian Cancer Risk Screening for Ovarian Cancer-----------------------------------
Mon, 21 Jul 2025 - 19min - 580 - Early-Onset Gastrointestinal Cancers
Early-onset gastrointestinal cancers, typically defined as occurring in patients younger than age 50, are increasing worldwide. A recent JAMA Review summarizes current data on early-onset colorectal, pancreatic, and esophagogastric cancers. Coauthor Kimmie Ng, MD, MPH, of Dana-Farber Cancer Institute joins JAMA Deputy Editor Kristin Walter, MD, MS to discuss. Related Content:
Early-Onset Gastrointestinal Cancers Screening for Helicobacter pylori to Prevent Gastric Cancer First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer-----------------------------------
Thu, 17 Jul 2025 - 24min - 579 - Managing Lower Urinary Tract Symptoms in Men
Approximately 40% of men older than 50 have urinary frequency or urgency that affects their quality of life. Author John T. Wei, MD, MS, of the University of Michigan Department of Urology and JAMA Deputy Editor Mary M. McDermott, MD, discuss diagnosis and management of these symptoms in older men. Related Content:
Lower Urinary Tract Symptoms in Men-----------------------------------
Mon, 14 Jul 2025 - 16min - 578 - West Nile Virus
In the 25 years since its emergence in the US, West Nile virus has become the leading cause of domestic mosquito-borne disease. It causes approximately 1300 neuroinvasive disease cases and 130 deaths annually in the US. Coauthor Carolyn Gould, MD, of the CDC joins JAMA Senior Editor Karen Lasser, MD, to discuss the review on this topic published in JAMA. Related Content:
West Nile Virus What Is West Nile Virus Infection?-----------------------------------
Mon, 07 Jul 2025 - 14min - 577 - Treatment and Management of Osteoporosis
Worldwide, 1 in 3 women and 1 in 5 men older than 50 years experience osteoporotic fractures in their lifetime. Author Suzanne N. Morin, MD, MSc, of McGill University and JAMA Deputy Editor Mary M. McDermott, MD, discuss the diagnosis and management of osteoporosis. Related Content:
OsteoporosisMon, 30 Jun 2025 - 23min - 576 - Type 2 Diabetes: Diagnosis and Current Guidelines for Treatment
Which tests can be used to diagnose type 2 diabetes? When should injectable medications for type 2 diabetes be started? These are just some of the questions clinicians may have when diagnosing and treating type 2 diabetes in adults. Author Rita Kalyani, MD, MHS, of Johns Hopkins University School of Medicine, discusses this and more with JAMA Senior Editor Karen Lasser, MD, MPH. Related Content:
Diagnosis and Treatment of Type 2 Diabetes in AdultsMon, 23 Jun 2025 - 20min - 575 - Adrenal Insufficiency in Adults
Adrenal insufficiency is a syndrome of cortisol deficiency. A recent JAMA Review summarizes the pathophysiology, diagnosis, and treatment of adrenal insufficiency and adrenal crisis. JAMA Associate Editor David Simel, MD, MHS, discusses this and more with author Anand Vaidya, MD, MMSc. Related Content:
Adrenal Insufficiency in AdultsMon, 16 Jun 2025 - 18min - 574 - From the JAMA Network: Comprehensive Review of Foley Catheter Management
Interview with Anne P. Cameron, MD and Glenn T. Werneburg, MD, PhD, authors of Foley Catheter Management: A Review. Hosted by Amalia Cochran, MD. Related Content:
Foley Catheter ManagementThu, 12 Jun 2025 - 18min - 573 - How to Improve Patients' Treatment Expectations
Patients' treatment expectations may affect their treatment outcomes. Coauthor Johannes A. C. Laferton, PhD, joins JAMA Senior Editor Anne Cappola, MD, ScM, to discuss the latest article in JAMA's Communicating Medicine series, which explores how to help patients have a better experience and better outcomes with treatment. Related Content:
Improving Patients' Treatment ExpectationsWed, 04 Jun 2025 - 18min - 572 - Lipoprotein(a): What Clinicians Should Know
Elevated levels of lipoprotein(a) are associated with higher rates of cardiovascular events. Author Samia Mora, MD, MHS, of Brigham and Women's Hospital and Harvard Medical School discusses measurement and interpretation of lipoprotein (a) levels with JAMA Deputy Editor Mary McGrae McDermott, MD. Related Content:
Lipoprotein(a)Tue, 03 Jun 2025 - 19min - 571 - Platelet Transfusion: Best Practice Guidelines
A central question in platelet transfusion is whether to follow a restrictive or liberal strategy in decisions about which patients should receive platelets. Author Ryan Metcalf, MD, University of Utah, discusses new clinical guidelines for platelet transfusion and more with JAMA Executive Editor Gregory Curfman, MD. Related Content:
Platelet Transfusion Red Blood Cell Transfusion in the Intensive Care Unit Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care Red Blood Cell Transfusion Trends in Red Blood Cell, Plasma, and Platelet Transfusions in the United States, 1993-2014Thu, 29 May 2025 - 13min - 570 - Immune Thrombotic Thrombocytopenic Purpura (iTTP)
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare coagulopathic disorder characterized by immune-mediated thrombocytopenia and microangiopathic hemolytic anemia, that can cause life-threatening thrombosis. Coauthor Allyson M. Pishko, MD, MSCE, of the University of Pennsylvania joins JAMA Associate Editor David Simel, MD, MHS, to discuss the recent review of iTTP published in JAMA. Related Content:
Immune Thrombotic Thrombocytopenic PurpuraMon, 19 May 2025 - 21min - 569 - Microbiome and Risk for Cancer Outcomes
The human microbiome appears to influence risk for development and progression of cancer and response to treatment. Author Jennifer Wargo, MD, University of Texas M.D. Anderson Cancer Center, discusses basic science and clinical evidence regarding the human microbiome and cancer risk with JAMA Deputy Editor Mary McGrae McDermott, MD. Related Content:
The Microbiome and CancerMon, 12 May 2025 - 18min - 568 - Diagnosis and Treatment of Endometriosis
Endometriosis, a common cause of pelvic pain, affects approximately 10% of reproductive-age females. Author Sawsan As-Sanie, MD, MPH, University of Michigan, discusses the epidemiology, pathophysiology, diagnosis, and treatment of endometriosis with JAMA Senior Editor Karen E. Lasser, MD, MPH. Related Content:
EndometriosisMon, 05 May 2025 - 15min - 567 - Strategies for Talking With Parents About Vaccines
What is the single most important thing to recognize when communicating with families about vaccines? Author Sean T. O'Leary, MD, MPH, of the University of Colorado Anschutz Medical Campus and Children's Hospital Colorado joins JAMA Senior Editor Anne Cappola, MD, ScM, to discuss evidence-based approaches for discussions with parents about vaccines. Related Content:
Strategies for Communicating With Parents About VaccinesWed, 30 Apr 2025 - 13min - 566 - Non–Cystic Fibrosis (CF) Bronchiectasis in Adults
Non-cystic fibrosis (CF) bronchiectasis, which affects approximately a half million people in the US, is a chronic lung condition that involves permanent bronchial dilation and inflammation; it is characterized by a productive cough and recurrent exacerbations. Author Alan F. Barker, MD, of Oregon Health and Science University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss non-CF bronchiectasis. Related Content:
Non–Cystic Fibrosis Bronchiectasis in AdultsMon, 28 Apr 2025 - 23min - 565 - Vitamin D Guidelines for Healthy Children and Adults
A JAMA Clinical Guidelines Synopsis summarizes the Endocrine Society's most recent recommendations on vitamin D supplementation for disease prevention. Author Sherri-Ann M. Burnett-Bowie, MD, MPH, discusses this and more with JAMA Associate Editor David L. Simel, MD, MHS. Related Content:
Vitamin D for Prevention of DiseaseWed, 23 Apr 2025 - 18min - 564 - Discussing Surgery With Patients
What are 3 fundamental communication skills needed when discussing surgery with patients? Author Lauren J. Taylor, MD, of the Central Virginia VA Health Care System discusses this and more with JAMA Senior Editor Anne Cappola, MD, ScM. Related Content:
Communicating With Patients About SurgeryWed, 16 Apr 2025 - 12min - 563 - Treatment of Small Cell Lung Cancer
Small cell lung cancer (SCLC) is a smoking-related malignancy that presents at an advanced stage in 70% of patients. Author Anne C. Chiang, MD, PhD, of the Yale University School of Medicine joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the epidemiology, treatment, and prognosis of SCLC. Related Content:
Small Cell Lung CancerMon, 31 Mar 2025 - 11min - 562 - Diagnosis, Treatment, and Prognosis of Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Adults
Polycystic kidney disease is the most common genetic kidney disease worldwide and is characterized by progressive development of kidney cysts. Author Nerra Dahl, MD, PhD, Mayo Clinic, discusses the pathophysiology, clinical presentation, diagnosis, prognosis, and treatment of ADPKD in adults, with JAMA Associate Editor David Simel, MD, MHS. Related Content:
Autosomal Dominant Polycystic Kidney DiseaseMon, 24 Mar 2025 - 22min - 561 - Chronic Myeloid Leukemia: A Review
Chronic myeloid leukemia is a myeloproliferative neoplasm that affects approximately 5 million people worldwide. Tyrosine kinase inhibitors, such as imatinib, have substantially improved survival in patients with chronic myeloid leukemia. In this podcast, author Elias J. Jabbour, MD, of the University of Texas MD Anderson Cancer Center, discusses diagnosis and treatment of chronic myeloid leukemia with JAMA Deputy Editor Mary McDermott, MD. Related Content:
Chronic Myeloid LeukemiaMon, 17 Mar 2025 - 17min - 560 - USPSTF Recommendation: Screening for Food Insecurity
Interview with Tumaini Rucker Coker, MD, MBA, USPSTF member and coauthor of Screening for Food Insecurity: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content:
Preventive Services for Food Insecurity Food Insecurity, Health, and Health Care in the US Navigating the Complexity of Food Insecurity Screening Screening for Food Insecurity US Preventive Services Task Force Recommendations for Screening for Food Insecurity Screening for Food InsecurityTue, 11 Mar 2025 - 13min - 559 - Localized and Metastatic Prostate Cancer
Prostate cancer is the most common nonskin cancer in men in the US and the second most common cancer in men worldwide. Author R. Bruce Montgomery, MD, of the University of Washington joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence regarding the epidemiology, diagnosis, and management of localized and metastatic prostate cancer. Related Content:
Prostate CancerMon, 10 Mar 2025 - 18min - 558 - Eating Disorders: A Review
A recent JAMA article reviews the 3 most common eating disorders, their risk factors, diagnosis and treatment. In this podcast, coauthors Evelyn Attia, MD, and Timothy Walsh, MD, both from Columbia University Irving Medical Center, discuss eating disorders with JAMA Deputy Editor Kristin Walter, MD, MS. Related Content:
Eating DisordersThu, 06 Mar 2025 - 20min - 557 - A New Legal Standard for Medical Malpractice From the American Law Institute
In 2024, the American Law Institute revised the legal standard for assessing medical negligence. Author Christopher T. Robertson, JD, PhD, of Boston University School of Law joins JAMA Executive Editor Gregory Curfman, MD, to discuss these changes in the first-ever restatement of the law. Related Content:
A New Legal Standard for Medical Malpractice Another Medical Malpractice Crisis?Wed, 26 Feb 2025 - 13min - 556 - Sudden Cardiac Arrest in Healthy Young Adults
Out-of-hospital cardiac arrest in apparently healthy adults younger than 40 years ranges from 4 to 14 per 100 000 person-years worldwide. Among young adults who have had cardiac arrest outside of a hospital, only 9% to 16% survive to hospital discharge. Author Zian Tseng, MD, MAS, University of California, San Francisco, discusses this and more with JAMA Associate Editor David L. Simel, MD, MHS. Related Content:
Out-of-Hospital Cardiac Arrest in Apparently Healthy, Young AdultsThu, 20 Feb 2025 - 16min - 555 - Pulmonary Rehabilitation Guidelines for Adults With Chronic Respiratory Disease
Guidelines from the American Thoracic Society report on the value of pulmonary rehabilitation for people with COPD, interstitial lung disease, or pulmonary hypertension. JAMA Clinical Guidelines Synopsis author Michaela R. Anderson, University of Pennsylvania, discusses these guidelines and more with JAMA Associate Editor David Simel, MD, MHS. Related Content:
Pulmonary Rehabilitation for Adults With Chronic Respiratory Disease Proper Use of Inhalant Medications for Chronic Respiratory DiseasesWed, 05 Feb 2025 - 17min - 554 - Essential Thrombocythemia
Essential thrombocythemia, a clonal myeloproliferative neoplasm with excessive platelet production, is associated with an increased risk of thrombosis and bleeding. Author Ayalew Tefferi, MD, of the Mayo Clinic, joins JAMA Associate Editor David Simel, MD, MHS, to discuss diagnosis and treatment of this condition. Related Content:
Essential ThrombocythemiaMon, 27 Jan 2025 - 23min
Podcasts similar to JAMA Clinical Reviews
El Partidazo de COPE COPE
Herrera en COPE COPE
La Linterna COPE
Es la Mañana de Federico esRadio
La noche de Cuesta esRadio
La Trinchera de Llamas esRadio
Hondelatte Raconte Europe 1
Affaires sensibles France Inter
LEGEND Guillaume Pley
El colegio invisible OndaCero
La Rosa de los Vientos OndaCero
Les grands dossiers de l'Histoire par Franck Ferrand Radio Classique
Espacio en blanco Radio Nacional
Entrez dans l'Histoire RTL
Le grand récit RTL
Les Grosses Têtes RTL
L'Heure Du Crime RTL
Parlons-nous RTL
El Larguero SER Podcast
Nadie Sabe Nada SER Podcast
SER Historia SER Podcast
Todo Concostrina SER Podcast
Un Libro Una Hora SER Podcast
HISTORIAS DE LA HISTORIA VIVA RADIO